Invex Therapeutics (ASX:IXC) Purchase Of Business : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Purchase Of Business?

Invex Therapeutics's purchase of business for the six months ended in Dec. 2024 was A$0.00 Mil. It means Invex Therapeutics spent A$0.00 Mil on purchasing business. Invex Therapeutics's purchase of business for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2024 ), Invex Therapeutics spent the same money on purchasing business in Dec. 2024 (A$0.00 Mil).

Invex Therapeutics Purchase Of Business Historical Data

The historical data trend for Invex Therapeutics's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics Purchase Of Business Chart

Invex Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Purchase Of Business

Invex Therapeutics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Purchase Of Business	Get a 7-Day Free Trial						-	-	-	-	-

Invex Therapeutics Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Invex Therapeutics Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Invex Therapeutics's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Invex Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Purchase Of Business

Comparable Companies

Traded in Other Exchanges

N/A

Address

38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008

Website

https://www.invextherapeutics.com

Invex Therapeutics Ltd is a biopharmaceutical company, focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised ICP including TBI, stroke and hydrocephalus. In addition, the Group has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Geographically, it operates only in Australia.